What is presbyopia?

Presbyopia is the gradual loss of the eye's ability to focus on close objects. It is a normal age-related change that affects nearly everyone, typically starting to be noticeable in the early to mid-forties. The classic features are difficulty reading small print, holding a phone or menu farther away to see clearly, eyestrain or headache after reading, and difficulty focusing in dim light. Presbyopia is not a disease and does not cause vision loss; it is a change in how the eye focuses.

Why it happens. The eye focuses on close objects by changing the shape of its lens, a process called accommodation. The lens is a flexible structure inside the eye, and its shape is adjusted by tiny muscles around it. As the lens ages, it becomes stiffer and less able to change shape, so accommodation gradually decreases. The change is steady and predictable through middle age and continues more slowly into older age.

The traditional options.

Reading glasses or bifocals: the simplest, most-effective, and most-flexible solution for most people. Over-the-counter readers work well for many; prescription glasses are needed when distance vision also requires correction.

Contact lenses: monovision (one eye corrected for distance, one for near) and multifocal contact lenses can address presbyopia for contact-lens wearers.

Surgical correction: monovision LASIK or PRK applies the same monovision principle surgically. Refractive lens exchange replaces the natural lens with a multifocal or extended-depth-of-focus intraocular lens, providing functional vision at multiple distances. Cataract surgery in the right age group is also an opportunity to address presbyopia by choosing an appropriate intraocular lens.

The new pharmacological option. Pilocarpine ophthalmic solution is an eye-drop that constricts the pupil and produces a 'pinhole effect' that increases depth of focus, improving reading vision for several hours after a drop. It works for many people for moderate amounts of close work but has trade-offs: dim-vision difficulty, sometimes headache or brow ache. Follow-on medicines in the same class with improved tolerability are in late-stage trials. A different mechanism approach, targeting lens elasticity directly, is also reading out and might offer reading vision without the miotic-class side effects.

What to expect. Presbyopia is universal but very treatable. Most people find a workable approach with one or a combination of these options, depending on lifestyle, occupation, other vision needs, and preference. The conversation with an eye-care provider centres on what visual demands matter most to you and which combination of approaches best matches.